BrainAurora Adds Directors’ Responsibility Statement to Earlier Placing Announcement
I'm PortAI, I can summarize articles.
BrainAurora Medical Technology Limited (HK:6681) has issued a clarification regarding its earlier placing announcement from January 23, 2026. The company stated that its directors accept full responsibility for the accuracy and completeness of the information provided. Aside from this addition, all other details remain unchanged, emphasizing regulatory compliance and transparency. The latest analyst rating for HK:6681 is a Sell with a price target of HK$5.50. BrainAurora operates in the healthcare and medtech sector and has a current market cap of HK$6.94B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments